FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034118721> ?p ?o ?g. }

• W2034118721 endingPage "1493" @default.
• W2034118721 startingPage "1483" @default.
• W2034118721 abstract "First line immunosuppressive treatment in steroid-resistant nephrotic syndrome in children is still open to discussion. We conducted a controlled multicentre randomized open label trial to test the efficacy and safety of cyclosporin A (CSA) versus cyclophosphamide pulses (CPH) in the initial therapy of children with newly diagnosed primary steroid-resistant nephrotic syndrome and histologically proven minimal change disease, focal segmental glomerulosclerosis or mesangial hypercellularity. Patients in the CSA group (n = 15) were initially treated with 150 mg/m2 CSA orally to achieve trough levels of 120–180 ng/ml, while patients in the CPH group (n = 17) received CPH pulses (500 mg/m2 per month intravenous). All patients were on alternate prednisone therapy. Patients with proteinuria >40 mg/m2 per hour at 12 weeks of therapy were allocated to a non-responder protocol with high-dose CSA therapy or methylprednisolone pulses. At week 12, nine of the 15 (60%) CSA patients showed at least partial remission, evidences by a reduction of proteinuria <40 mg/h per m2. In contrast, three of the 17 (17%) CPH patients responded (p < 0.05, intention-to-treat). Given these results, the study was stopped, in accordance with the protocol. After 24 weeks, complete remission was reached by two of the 15 (13%) CSA and one of the 17 (5%) CPH patients (p = n.s.). Partial remission was achieved by seven of the 15 (46%) CSA and two of the 15 (11%) CPH patients (p <0.05). Five patients in the CSA group and 14 patients in the CPH group were withdrawn from the study, most of them during the non-responder protocol. The number of adverse events was comparable between both groups. We conclude that CSA is more effective than CPH in inducing at least partial remission in steroid-resistant nephrotic syndrome in children." @default.
• W2034118721 created "2016-06-24" @default.
• W2034118721 creator A5015077988 @default.
• W2034118721 creator A5040285474 @default.
• W2034118721 creator A5057087501 @default.
• W2034118721 creator A5070999622 @default.
• W2034118721 creator A5079173500 @default.
• W2034118721 creator A5091606062 @default.
• W2034118721 date "2008-09-01" @default.
• W2034118721 modified "2023-09-24" @default.
• W2034118721 title "Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome—a randomized controlled multicentre trial by the Arbeitsgemeinschaft für Pädiatrische Nephrologie" @default.
• W2034118721 cites W1893388478 @default.
• W2034118721 cites W1972310654 @default.
• W2034118721 cites W1974796597 @default.
• W2034118721 cites W1981507875 @default.
• W2034118721 cites W1984052453 @default.
• W2034118721 cites W1993387604 @default.
• W2034118721 cites W1994069320 @default.
• W2034118721 cites W1999616292 @default.
• W2034118721 cites W2004509350 @default.
• W2034118721 cites W2005167968 @default.
• W2034118721 cites W2010580624 @default.
• W2034118721 cites W2017629206 @default.
• W2034118721 cites W2017969415 @default.
• W2034118721 cites W2027272349 @default.
• W2034118721 cites W2028552051 @default.
• W2034118721 cites W2031799718 @default.
• W2034118721 cites W2037446344 @default.
• W2034118721 cites W2047135575 @default.
• W2034118721 cites W2054627468 @default.
• W2034118721 cites W2059026853 @default.
• W2034118721 cites W2059769088 @default.
• W2034118721 cites W2088245011 @default.
• W2034118721 cites W2088623598 @default.
• W2034118721 cites W2090481397 @default.
• W2034118721 cites W2103667874 @default.
• W2034118721 cites W2115042832 @default.
• W2034118721 cites W2126226666 @default.
• W2034118721 cites W2127383350 @default.
• W2034118721 cites W2134567663 @default.
• W2034118721 cites W2148907335 @default.
• W2034118721 cites W2159526233 @default.
• W2034118721 cites W2167019152 @default.
• W2034118721 cites W2249348969 @default.
• W2034118721 cites W2316086035 @default.
• W2034118721 cites W4210848327 @default.
• W2034118721 cites W4230414264 @default.
• W2034118721 cites W71740026 @default.
• W2034118721 doi "https://doi.org/10.1007/s00467-008-0794-1" @default.
• W2034118721 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2730636" @default.
• W2034118721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18481113" @default.
• W2034118721 hasPublicationYear "2008" @default.
• W2034118721 type Work @default.
• W2034118721 sameAs 2034118721 @default.
• W2034118721 citedByCount "93" @default.
• W2034118721 countsByYear W20341187212012 @default.
• W2034118721 countsByYear W20341187212013 @default.
• W2034118721 countsByYear W20341187212014 @default.
• W2034118721 countsByYear W20341187212015 @default.
• W2034118721 countsByYear W20341187212016 @default.
• W2034118721 countsByYear W20341187212017 @default.
• W2034118721 countsByYear W20341187212018 @default.
• W2034118721 countsByYear W20341187212019 @default.
• W2034118721 countsByYear W20341187212020 @default.
• W2034118721 countsByYear W20341187212021 @default.
• W2034118721 countsByYear W20341187212022 @default.
• W2034118721 crossrefType "journal-article" @default.
• W2034118721 hasAuthorship W2034118721A5015077988 @default.
• W2034118721 hasAuthorship W2034118721A5040285474 @default.
• W2034118721 hasAuthorship W2034118721A5057087501 @default.
• W2034118721 hasAuthorship W2034118721A5070999622 @default.
• W2034118721 hasAuthorship W2034118721A5079173500 @default.
• W2034118721 hasAuthorship W2034118721A5091606062 @default.
• W2034118721 hasBestOaLocation W20341187212 @default.
• W2034118721 hasConcept C126322002 @default.
• W2034118721 hasConcept C126894567 @default.
• W2034118721 hasConcept C141071460 @default.
• W2034118721 hasConcept C168563851 @default.
• W2034118721 hasConcept C2776694085 @default.
• W2034118721 hasConcept C2776755627 @default.
• W2034118721 hasConcept C2777747828 @default.
• W2034118721 hasConcept C2778415529 @default.
• W2034118721 hasConcept C2778720950 @default.
• W2034118721 hasConcept C2778930706 @default.
• W2034118721 hasConcept C2779561371 @default.
• W2034118721 hasConcept C2780091579 @default.
• W2034118721 hasConcept C2780372218 @default.
• W2034118721 hasConcept C54847362 @default.
• W2034118721 hasConcept C71924100 @default.
• W2034118721 hasConcept C90924648 @default.
• W2034118721 hasConceptScore W2034118721C126322002 @default.
• W2034118721 hasConceptScore W2034118721C126894567 @default.
• W2034118721 hasConceptScore W2034118721C141071460 @default.
• W2034118721 hasConceptScore W2034118721C168563851 @default.
• W2034118721 hasConceptScore W2034118721C2776694085 @default.
• W2034118721 hasConceptScore W2034118721C2776755627 @default.
• W2034118721 hasConceptScore W2034118721C2777747828 @default.
• W2034118721 hasConceptScore W2034118721C2778415529 @default.

• next